contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


the-last-day-of-trading-with-the-warrants-of-series-to5-in-lumito-ab-is-today-june-4-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Lumito specializes in medical technology for digital pathology. The company strives to improve tissue diagnostics with its patented technology based on upconverted nanoparticles. The company plans to initially launch its first product for research laboratories. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito has its headquarters in Lund.

Lumito

Today, June 4, 2024, is the last day of trading with the warrants of series TO5 in Lumito AB (publ) (“Lumito” or the “Company”). The exercise period for the warrants runs up to and including...

<div class="mfn-preamble">Today, June 4, 2024, is the last day of trading with the warrants of series TO5 in Lumito AB (publ) (“Lumito” or the “Company”). The exercise period for the warrants runs up to and including June 10, 2024. Each warrant of series TO5 gives the owner the right to subscribe for one (1) new share in the Company for a subscription price of SEK 0.75 per share.</div><div class="mfn-body">Summarised terms for the warrants of series TO5: Exercise period: May 27, 2024 – June 10, 2024.Subscription price: SEK 0.75 per share.Issue volume: 34,406,248 warrants of series TO5 entitles to subscription of 34,406,248 shares. If all warrants are exercised the Company will receive approximately SEK 25.8 million before issuing costs.Last day for trading with warrants: June 4, 2024.Share capital and dilution: If all warrants of series TO5 are exercised the number of shares will increase with 34,406,248 shares from 206,437,488 shares to 240,843,736 shares and the share capital will increase with SEK 860,156.20, from SEK 5,160,937.20 to SEK 6,021,093.40, corresponding to a maximal dilution effect of 14.3 percent if the number of shares.Note that the warrants that are not exercised at the latest June 10, 2024, or sold at the latest June 4, 2024, will expire without value. For the warrants of series TO5 not to lose their value, the holder must actively subscribe for new shares or sell the warrants. Please note that some nominees may close registration earlier than June 10, 2024.Advisers Mangold Fondkommission AB is financial adviser and Advokatfirman Lindahl KB is legal advisor to Lumito in connection with the exercise of the warrants of series TO5.</div><div class="mfn-footer mfn-contacts mfn-1c72a901341e">For further information, please contact:<hr>Mattias Lundin, CEO Lumito E-mail:&nbsp;<a rel="noopener" href="mailto:ml@lumito.se">ml@lumito.se</a> Ph: +46 76 868 45 09&nbsp;</div><div class="mfn-footer mfn-about mfn-a888ce5bf1d4">Lumito<hr>Lumito&nbsp;specialises in medical technology for digital pathology. Through its proprietary and patented technology, Lumito aims to provide healthcare providers with a powerful tool to meet the demands for fast and safe tissue diagnostics in personalised healthcare. The technology enables higher-contrast images without irrelevant background information, making it easier for pathologists to find cancer indications. The technology, based on Up Converting NanoParticles (UCNP), has the potential to significantly improve the diagnosis of tissue samples through higher quality analyses and shortened analysis times. The method has several potential applications, but Lumito has focused primarily on digital pathology and first on a release of SCIZYS by Lumito for use in research laboratories. The&nbsp;company is a spin-off of a research group at the Department of Atomic Physics and Laser Centre.&nbsp;<a rel="noopener" href="http://www.lumito.se/en">www.lumito.se/en</a>The share is traded on NGM Nordic SME under the name LUMITO, and Mentor is Mangold Fondkommission.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments <a rel="noopener" href="https://storage.mfn.se/371ded77-8406-4b09-b881-6c373a438b65/the-last-day-of-trading-with-the-warrants-of-series-to5-in-lumito-ab-is-today-june-4-2024.pdf" class="mfn-generated mfn-primary">The last day of trading with the warrants of series TO5 in Lumito AB is today, June 4, 2024</a></div>

The last day of trading with the warrants of series TO5 in Lumito AB is today, June 4, 2024

Wall Streetin arvostustasoihin verrattuna Eurooppakin näyttää nyt houkuttelevalta

Federal Reserven korkopäätös: Kiire loppui tähän

Lääkekehityssijoittaminen: Arvonluonti yrityskaupoilla ja lisensointisopimuksilla

EKP:n korkopäätös: Keskuspankki ilman rajoitteita

Euroalueen ostopäälliköt: Onks sen jälkeen vielä mäki?

Pysy ajantasalla Inderesin uutiskirjeillä